Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-02-17
Product name
HYCAMTIN INJECTABLE
Product Synonyms
HYCAMTIN INFUSION 1 MG/3 ML * HYCAMTIN INJECTION 1 MG/3 ML * HYCAMTIN INJECTION
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity following single Category 1 exposure
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
Fatal if swallowed. Causes serious eye damage. May cause genetic defects. May cause cancer. May damage fertility or the unborn child. Causes damage to organs.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection.
Response
IF SWALLOWED Immediately call a POISON CENTRE/doctor/. Rinse mouth. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE/doctor/.
Storage
Store locked up.
Disposal
Dispose of contents/container to
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
10 % of the mixture consists of component(s) of unknown acute dermal toxicity.
